Editorial: New mechanisms and drugs for the treatment of cardiovascular disease with diabetes

Editorial: New mechanisms and drugs for the treatment of cardiovascular disease with diabetes

Bibliographic Details
Main Authors:	Shanshan Zhang, Jingwei Li, Yuli Huang, Jie Yu, Xiong-Fei Pan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	diabetes cardiovascular diseases mechanisms drugs cardiovascular therapeutics oxidative stress
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1144858/full

Similar Items

Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease
by: Aikaterini Andreadi, et al.
Published: (2023-01-01)

Oxidative stress : a focus on cardiovascular disease pathogensis /
by: Matata, Bashir M., et al.
Published: (2010)

Cardiovascular disease and diabetes /
by: Clark, Luther T., et al.
Published: (2007)

The Role of Platelets in Hypoglycemia-Induced Cardiovascular Disease: A Review of the Literature
by: Ahmed Ali Gebril Ali, et al.
Published: (2023-01-01)

Functional foods, cardiovascular disease and diabetes /
by: Arnold, A.
Published: (2004)

Editorial: Cardiovascular remodeling
by: Yan Yang, et al.
Published: (2023-07-01)

Editorial: Mechanism and therapeutic potential of macrophages in metabolic and cardiovascular diseases
by: Xuqiang Nie, et al.
Published: (2023-12-01)

The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease
by: Yi Zhang, et al.
Published: (2023-01-01)

Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies
by: Vladimir V. Salukhov, et al.
Published: (2018-08-01)

Cardiovascular Magnetic Resonance Imaging as an Adjunct to the Evaluation of Cardiovascular Involvement in Diabetes Mellitus
by: Sophie I. Mavrogeni, et al.
Published: (2023-04-01)

Diabetes and cardiovascular disease /
by: Johnstone, Michael T., et al.
Published: (2005)

Metformin and its redox-related mechanisms of action in type 2 diabetes
by: Teresa Vezza, et al.
Published: (2023-10-01)

Oxidative stress and metabolic parameters in hypertensive patients with/without diabetes mellitus in cardiovascular risk evaluation
by: Nemes-Nagy Enikő, et al.
Published: (2022-10-01)

Update of cardiovascular autonomic neuropathy in patients with diabetes
by: Andra-Elena Nica, et al.
Published: (2021-06-01)

Beyond Ion Homeostasis: Hypomagnesemia, Transient Receptor Potential Melastatin Channel 7, Mitochondrial Function, and Inflammation
by: Man Liu, et al.
Published: (2023-09-01)

Table 3: Cardiovascular effects of anti-diabetic drugs
by: Pablo Javier Avila, et al.
Published: (2020-09-01)

Glucose Intake and Utilization in Pre-Diabetes and Diabetes : Implications for Cardiovascular Disease /
by: Watson, Ronald R., et al.
Published: (2015)

Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Türkiye Cohort
by: Aytekin Oğuz, et al.
Published: (2023-07-01)

Recommendations guide for patients with diabetes mellitus and cardiovascular disease
by: León Litwak
Published: (2021-02-01)

Effects of diabetes mellitus and glycemic traits on cardiovascular morpho-functional phenotypes
by: Zhaoyue Li, et al.
Published: (2023-12-01)

Drug-associated cardiovascular risks: A retrospective evaluation of withdrawn drugs
by: Kumsal Kocadal, et al.
Published: (2019-06-01)

Impacts of Pre-Diabetes or Prehypertension on Subsequent Occurrence of Cardiovascular and All-Cause Mortality among Population without Cardiovascular Diseases
by: Huang Y, et al.
Published: (2020-05-01)

A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs
by: Yang Lu, et al.
Published: (2022-11-01)

Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022
by: Keman Xu, et al.
Published: (2023-10-01)

Cardiovascular diseases: Interplay of epigenetics
by: Yog R. Ahuja, et al.
Published: (2017-01-01)

Plant Polyphenols and Their Potential Benefits on Cardiovascular Health: A Review
by: Iram Iqbal, et al.
Published: (2023-09-01)

Cardiovascular disease and diabetes
by: Silvio Schraier
Published: (2020-09-01)

Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders—Is There a Breakthrough?
by: Jelica Grujić-Milanović, et al.
Published: (2023-12-01)

Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016–2020
by: Ursula Kirchmayer, et al.
Published: (2024-03-01)

Therapeutic education of patients with Type 2 diabetes mellitus and high cardiovascular risk
by: E. A. Palferova, et al.
Published: (2007-12-01)

Algorithm for Diagnosing Cardiovascular Pathology in Diabetes Mellitus
by: Vasilkova, V.M., et al.
Published: (2023-12-01)

Editorial: Cardiovascular diseases related to diabetes and obesity, volume III
by: Ying Xin, et al.
Published: (2024-02-01)

Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes
by: Damien Denimal
Published: (2023-12-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study
by: Xuelin Yao, et al.
Published: (2023-05-01)

Roles and Therapeutic Implications of Endoplasmic Reticulum Stress and Oxidative Stress in Cardiovascular Diseases
by: Yan Zhou, et al.
Published: (2021-07-01)

A Call to Action to Address the Burden of Cardiovascular Disease in People with Diabetes
by: Karolay Lorenty, et al.
Published: (2022-12-01)

The Effect of Alcohol on Cardiovascular Risk Factors: Is There New Information?
by: Simona Minzer, et al.
Published: (2020-03-01)

Impacto de la diabetes en el riesgo cardiovascular en pacientes con dislipidemia
by: Gregorio Peña-Rodríguez, et al.
Published: (2024-04-01)

Associations of polyneuropathy with risk of all‐cause and cardiovascular mortality, cardiovascular disease events stratified by diabetes status
by: Kyuho Kim, et al.
Published: (2023-11-01)